Approval · Notice of Compliance 36073 · 2025
AGAMREE: Notice of Compliance 36073
Issued September 29, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36073
- Date
- September 29, 2025
- Company
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGAMREE | 02561506 | Marketed |
Medicinal ingredients
- VAMOROLONE 40 MG per ML